Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy
Purpose
The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) mindfulness training (MT) plus wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. The primary outcome is study feasibility.
Condition
- Preeclampsia
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Pregnant patients at gestational age <= 16 weeks - Live, non-anomalous gestation - Normotensive at enrollment - Meet criteria consistent with 'moderate' to 'high' risk for preeclampsia based on ACOG/USPSTF guidelines for low-dose aspirin administration to prevent hypertensive disorders of pregnancy
Exclusion Criteria
- Multiple gestation - Chronic (pregestational hypertension) - Inability of unwillingness to provide informed consent - Active suicidality or psychosis - Ongoing mind-body practice (e.g., yoga, meditation, mindfulness >= once per week)
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Prevention
- Masking
- Single (Participant)
- Masking Description
- All participants will wear a Garmin Vivoactive 4 biosensor watch throughout the study. However, only one of the arms will have real-time access to thier data, while the other 2 arms will be masked to their watch data. The study team will have access to the watch data for all 3 arms.
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental MT + Biofeedback |
Mindfulness training plus self-monitoring with access to data from wearable biosensor |
|
|
Experimental MT |
Mindfulness training (no access to wearable biosensor data) |
|
|
No Intervention Control |
Routine prenatal care alone |
|
Recruiting Locations
Providence, Rhode Island 02904
Milwaukee, Wisconsin 53226
More Details
- Status
- Recruiting
- Sponsor
- Medical College of Wisconsin
Detailed Description
The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) MT + wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. All participants will wear Garmin Vivoactive 4 watches. Blood pressure, heart rate, heart rate variability, perceived stress, and pregnancy-related anxiety will be assessed at baseline (≤16 weeks), post-intervention (~24 weeks), and after each booster (~28 and 32 weeks). Feasibility, fidelity, and acceptability outcomes will be assessed after each post-intervention